Neurogene Income Statement (2013-2026) | NGNE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)													0.00B
Operating items
Research & Development (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.02B	0.03B	0.03B
Operating Income (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.02B	-0.03B	-0.03B
EBIT (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.02B	-0.03B	-0.03B
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)								0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income (Quarter)											0.02B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Non Operating Income (Quarter)	-0.00B		0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B			0.02B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Net income details
EBT (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Income from Continuing Operations (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Consolidated Net Income (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Income towards Parent Company (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B
Additional items
EPS (Basic) (Quarter)	-0.27	-0.28	-0.27	-0.28	-0.28	-1.18	-135.89	-28.28	-26.68	-32.67	27.76	-1.00	-1.09	-1.19	-0.99	-1.08	-1.05	-0.99	-1.13	-1.39
EPS (Weighted Average and Diluted) (Quarter)	-0.27	-0.28	-0.27	-0.28	-0.28	-1.18	3.99		-26.68	-32.67	2.93	-1.00	-1.09	-1.19	-0.99	-1.08	-1.05	-0.99	-1.13	-1.39
Shares Outstanding (Weighted Average) (Quarter)	0.06B	0.06B	0.01B	0.01B	0.01B	0.01B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.02B	0.02B	0.02B	0.01B	0.02B	0.01B
Shares Outstanding (Diluted Average) (Quarter)	0.05B	0.06B	0.06B	0.06B	0.06B	0.01B			0.00B	0.00B	0.00B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
EBITDA (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.02B	-0.03B	-0.03B
Interest Expenses (Quarter)								0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B
Shares Outstanding (Quarter)	0.04B	0.04B	0.00B	0.01B	0.01B	0.01B	0.00B		0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B
Tax Rate (Quarter)

Research Tools

Developers

Neurogene Income Statement (2013-2026) | NGNE

Research Tools

Developers

Neurogene Income Statement (2013-2026) | NGNE

Create an account

Sign In

Reset Password